Complete Pricing Guide for International Patients
China has emerged as a leading destination for international cancer patients seeking high-quality, affordable oncology care. With 5 of the world's top 10 cancer hospitals (according to Nature Index), China offers:
The country's oncology hospitals treat more cancer patients annually than most other countries, giving their medical teams extensive experience with complex cases. International patients increasingly view China as a viable alternative to prohibitively expensive Western cancer care.
Chemotherapy remains one of the most common cancer treatments, and the cost difference between China and the US is substantial. Chinese hospitals produce many generic chemotherapy drugs domestically, significantly reducing prices.
| Chemotherapy Drug/Type | USA Cost (Per Cycle) | China Cost (Per Cycle) | Savings |
|---|---|---|---|
| General Chemotherapy (Taxane-based) | $10,000-30,000 | $1,500-4,000 | 80-85% |
| Platinum-based (Cisplatin/Carboplatin) | $8,000-20,000 | $1,200-3,500 | 80-85% |
| Targeted Chemotherapy (Anti-angiogenesis) | $15,000-40,000 | $3,000-8,000 | 75-80% |
| Immunochemotherapy (Combined) | $25,000-60,000 | $5,000-12,000 | 75-80% |
Expert Insight: Chinese medical oncology departments have refined chemotherapy protocols over decades of high-volume practice, and their safety records and efficacy rates are benchmarked against international standards.
Surgical oncology in China offers the same quality procedures—at a fraction of Western costs. Top Chinese surgeons often perform more surgeries annually than their Western counterparts due to China's large patient population.
| Surgery Type | USA Cost | China Cost | Savings |
|---|---|---|---|
| Breast Cancer (Mastectomy/Lumpectomy) | $50,000-80,000 | $8,000-15,000 | 70-80% |
| Lung Cancer (Lobectomy) | $80,000-150,000 | $15,000-30,000 | 75-80% |
| Colorectal Cancer Surgery | $60,000-100,000 | $12,000-20,000 | 75-80% |
| Liver Cancer (Resection) | $100,000-200,000 | $20,000-40,000 | 75-80% |
| Gastric Cancer (Gastrectomy) | $70,000-120,000 | $14,000-25,000 | 75-80% |
| Thyroid Cancer | $30,000-50,000 | $5,000-10,000 | 75-80% |
Minimally invasive and robotic-assisted surgeries are available at major Chinese cancer centers, often at 60-70% less than US prices for equivalent procedures.
Targeted therapies represent the cutting edge of precision oncology. China has invested heavily in this area and now produces biosimilar versions of many targeted drugs at dramatically lower prices.
| Targeted Therapy | USA Cost (Monthly) | China Cost (Monthly) | Savings |
|---|---|---|---|
| Tyrosine Kinase Inhibitors (Gefitinib, Erlotinib) | $8,000-15,000 | $1,500-3,000 | 75-80% |
| Monoclonal Antibodies (Trastuzumab) | $10,000-20,000 | $2,000-4,000 | 75-80% |
| PARP Inhibitors (Olaparib) | $15,000-25,000 | $3,000-6,000 | 75-80% |
| BTK Inhibitors (Ibrutinib) | $12,000-18,000 | $2,500-5,000 | 70-75% |
| Anti-angiogenesis (Bevacizumab) | $8,000-15,000 | $1,800-3,500 | 75-80% |
Connecting international patients with top Chinese hospitals.
Finding the right hospital in China can be overwhelming. Let us help — free, no commitment.
⏳ Most cases get a hospital match within 24 hours